By clicking “Accept All Cookies” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Privacy PolicyLatin America Viral Vectors and Plasmid DNA Manufacturing Market (By Vector Type: Adenovirus, Retrovirus, Adeno-Associated Virus (AAV), Lentivirus, Plasmids, Others; By Workflow: Upstream Manufacturing (Vector Amplification & Expansion, Vector Recovery/Harvesting), Downstream Manufacturing (Purification, Fill Finish); By Application Outlook: Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Research Applications; By End-use Outlook: Pharmaceutical and Biopharmaceutical Companies, Research Institutes; By Disease Outlook: Cancer, Genetic Disorders, Infectious Diseases, Others) Industry Size, Share, Growth, Trends 2025 to 2034
The Latin America viral vectors and plasmid DNA manufacturing market was valued at USD 304.98 million in 2024 and is expected to reach USD 1,707.81 million by 2034, expanding at an 18.8% CAGR fueled by rising gene therapy and vaccine development demand.
| Reports Attributes | Statistics |
| Market Size in 2024 | USD 1,592 Million |
| Market Size in 2025 | USD 1,912 Million |
| Market Size in 2031 | USD 5,737 Million |
| Market Size by 2034 | USD 9,939 Million |
| CAGR 2025 to 2034 | 20.1% |
| Base Year | 2024 |
| Forecast Period | 2025 to 2034 |
The Latin America vehicle-to-grid technology market is expanding at a decent pace, driven by growing EV adoption and government incentives to adopt sustainable transport practices. Commercial fleets, such as buses, taxis, and delivery vehicles, are a major driver of V2G expansion in these areas, with greater government support. Renewable energy integration also plays a crucial role, with V2G serving as a low-cost distributed option for companies. Additionally, the many motives for adopting V2G include addressing grid stress and outages, as well as managing power requirements across diverse settings. The increasing commitment to clean energy is expected to drive greater business for V2G technology as infrastructure development expands.
EV penetration is primarily driven by countries such as the Asia Pacific and North America, due to well-established infrastructure and consumer awareness. Compared to these regions and Latin America, EV adoption rates in some countries remain low, limiting the expansion of V2G technology. Lower EV adoption also limits advancements, such as bidirectional chargers and others that require higher capital.
The future landscape of the vehicle-to-grid technology market is highly driven by the increasing number of municipal fleets rolling out several V2G opportunities in their areas. The Latin American vehicle-to-grid technology market is expanding significantly, with these technologies being integrated into rural microgrid applications to stabilize energy supply and reduce reliance on traditional options. Additionally, the growing investments in directional charging stations, smart meters, and other infrastructure are expected to create several opportunities for V2G use in a reliable manner. The long-term use of this technology is expected to help the EV owners earn income by supplying energy. Companies like Nissan have already entered the Chilean market by introducing a bidirectional charging station.
AI and ML are being adopted in the Latin America vehicle-to-grid technology market, helping predict grid demand and EV availability to schedule charging in a way that optimizes energy use while maintaining battery health. As a result, the influence of AI is rising in delivery fleets due to higher operational requirements. The battery observation patterns are also expected to improve, with these systems providing suggestions for stabilizing the grid and managing grid loads. AI predictive analysis will also help monitor irregularities in activity, cyberattacks, and other faults in chargers, thereby managing the workload.
Brazil is a crucial country for V2G growth due to its rapid EV adoption, which creates opportunities for energy storage. The Electric Vehicle Association ABVE reported that EV sales in Brazil increased by 90%, reaching 177,360 units in 2024. The previous year’s EV sales record in the country was 93,930. This data represents the growth of the Latin America vehicle-to-grid technology market, which will help drive renewable energy storage.
Argentina is expected to emerge as a crucial player in V2G growth due to its higher renewable energy capacity, which supports the adoption of sustainable energy storage solutions. Moreover, the government is also supporting the rise of EVs by providing incentives to buyers, which can help stabilize the grid during peak demand. Additionally, academic research from the National University of Rafaela in Argentina proposed integrating V2G systems with solar systems on its campus to optimize energy use and reduce the carbon footprint, identifying major opportunities for other companies in this business.
| Segments | Shares (%) |
| Adenovirus | 10% |
| Retrovirus | 7% |
| Adeno-Associated Virus (AAV) | 23% |
| Lentivirus | 16% |
| Plasmids | 42% |
| Others | 3% |
| Segments | Shares (%) |
| Upstream Manufacturing | 53% |
| Downstream Manufacturing | 47% |
| Segments | Shares (%) |
| Antisense & RNAi Therapy | 10% |
| Gene Therapy | 31% |
| Cell Therapy | 21% |
| Vaccinology | 19% |
| Research Applications | 19% |
| Segments | Shares (%) |
| Pharmaceutical and Biopharmaceutical Companies | 61% |
| Research Institutes | 39% |
| Segments | Shares (%) |
| Cancer | 31% |
| Genetic Disorders | 20% |
| Infectious Diseases | 44% |
| Others | 5% |
Published by Kesiya Chacko
| Vector Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adenovirus | 0.34 | 0.37 | 0.40 | 0.44 | 0.48 | 0.53 | 0.58 | 0.63 | 0.69 | 0.76 | 0.84 |
| Retrovirus | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| Adeno-Associated Virus (AAV) | 0.33 | 0.37 | 0.41 | 0.45 | 0.50 | 0.55 | 0.61 | 0.67 | 0.74 | 0.81 | 0.89 |
| Lentivirus | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 |
| Plasmids | 0.51 | 0.56 | 0.61 | 0.67 | 0.74 | 0.80 | 0.89 | 0.98 | 1.07 | 1.17 | 1.29 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Workflow | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vector Amplification & Expansion | 0.53 | 0.58 | 0.64 | 0.70 | 0.78 | 0.86 | 0.94 | 1.02 | 1.13 | 1.24 | 1.36 |
| Vector Recovery/Harvesting | 0.32 | 0.35 | 0.38 | 0.42 | 0.46 | 0.50 | 0.55 | 0.61 | 0.67 | 0.73 | 0.80 |
| Purification | 0.30 | 0.34 | 0.37 | 0.41 | 0.45 | 0.49 | 0.54 | 0.60 | 0.65 | 0.72 | 0.80 |
| Fill Finish | 0.05 | 0.06 | 0.07 | 0.07 | 0.08 | 0.08 | 0.09 | 0.10 | 0.11 | 0.12 | 0.13 |
| Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Adenovirus | 0.34 | 0.37 | 0.40 | 0.44 | 0.48 | 0.53 | 0.58 | 0.63 | 0.69 | 0.76 | 0.84 |
| Retrovirus | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| Adeno-Associated Virus (AAV) | 0.33 | 0.37 | 0.41 | 0.45 | 0.50 | 0.55 | 0.61 | 0.67 | 0.74 | 0.81 | 0.89 |
| Lentivirus | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | 0.05 | 0.05 | 0.06 |
| Plasmids | 0.51 | 0.56 | 0.61 | 0.67 | 0.74 | 0.80 | 0.89 | 0.98 | 1.07 | 1.17 | 1.29 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Subsegment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vector Amplification & Expansion | 0.53 | 0.58 | 0.64 | 0.70 | 0.78 | 0.86 | 0.94 | 1.02 | 1.13 | 1.24 | 1.36 |
| Vector Recovery/Harvesting | 0.32 | 0.35 | 0.38 | 0.42 | 0.46 | 0.50 | 0.55 | 0.61 | 0.67 | 0.73 | 0.80 |
| Purification | 0.30 | 0.34 | 0.37 | 0.41 | 0.45 | 0.49 | 0.54 | 0.60 | 0.65 | 0.72 | 0.80 |
| Fill Finish | 0.05 | 0.06 | 0.07 | 0.07 | 0.08 | 0.08 | 0.09 | 0.10 | 0.11 | 0.12 | 0.13 |
To get full access to our Market Insights, you need a Professional Account or a Business Suite.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
Our customers work more efficiently and benefit from
